These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23978005)

  • 1. Lymphatic transport of puerarin occurs after oral administration of different lipid-based formulations to unconscious lymph duct-cannulated rats.
    Zhou A; Lu T; Wang L; Lu C; Wang L; Wan M; Wu H
    Pharm Dev Technol; 2014 Sep; 19(6):743-7. PubMed ID: 23978005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
    Wu H; Zhou A; Lu C; Wang L
    Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs.
    Lespine A; Chanoit G; Bousquet-Melou A; Lallemand E; Bassissi FM; Alvinerie M; Toutain PL
    Eur J Pharm Sci; 2006 Jan; 27(1):37-43. PubMed ID: 16198549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
    White KL; Nguyen G; Charman WN; Edwards GA; Faassen WA; Porter CJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):700-9. PubMed ID: 19696095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor.
    Hauss DJ; Fogal SE; Ficorilli JV; Price CA; Roy T; Jayaraj AA; Keirns JJ
    J Pharm Sci; 1998 Feb; 87(2):164-9. PubMed ID: 9519148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model.
    Griffin BT; O'Driscoll CM
    J Pharm Pharmacol; 2006 Jul; 58(7):917-25. PubMed ID: 16805951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of microemulsion enhancing the oral bioavailability of puerarin: comparison between oil-in-water and water-in-oil microemulsions using the single-pass intestinal perfusion method and a chylomicron flow blocking approach.
    Tang TT; Hu XB; Liao DH; Liu XY; Xiang DX
    Int J Nanomedicine; 2013; 8():4415-26. PubMed ID: 24277986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration.
    Luo CF; Yuan M; Chen MS; Liu SM; Zhu L; Huang BY; Liu XW; Xiong W
    Int J Pharm; 2011 May; 410(1-2):138-44. PubMed ID: 21392565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion.
    Porter CJ; Charman SA; Charman WN
    J Pharm Sci; 1996 Apr; 85(4):351-6. PubMed ID: 8901067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of intestinal lymphatic transport on the systemic exposure and brain deposition of a novel highly lipophilic compound with structural similarity to cholesterol.
    Caliph SM; Faassen FW; Porter CJ
    J Pharm Pharmacol; 2014 Oct; 66(10):1377-87. PubMed ID: 24821499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model.
    Dong Z; Guo J; Xing X; Zhang X; Du Y; Lu Q
    Biomed Pharmacother; 2017 May; 89():297-304. PubMed ID: 28236703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absorption transport mechanism of puerarin oil-in-oil nanoemulsion].
    Pan E; Wu H; Lu C; Gui S; Wang L
    Zhongguo Zhong Yao Za Zhi; 2010 Oct; 35(20):2674-8. PubMed ID: 21246816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs.
    Khoo SM; Shackleford DM; Porter CJ; Edwards GA; Charman WN
    Pharm Res; 2003 Sep; 20(9):1460-5. PubMed ID: 14567642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of particle size on the pharmacokinetics of puerarin nanocrystals and microcrystals after oral administration to rat.
    Tu L; Yi Y; Wu W; Hu F; Hu K; Feng J
    Int J Pharm; 2013 Dec; 458(1):135-40. PubMed ID: 24120729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of bile on the absorption of halofantrine from lipid-based formulations.
    Holm R; Tønsberg H; Jørgensen EB; Abedinpour P; Farsad S; Müllertz A
    Eur J Pharm Biopharm; 2012 Jun; 81(2):281-7. PubMed ID: 22465095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic transport and catabolism of therapeutic proteins after subcutaneous administration to rats and dogs.
    Wang W; Chen N; Shen X; Cunningham P; Fauty S; Michel K; Wang B; Hong X; Adreani C; Nunes CN; Johnson CV; Yin KC; Groff M; Zou Y; Liu L; Hamuro L; Prueksaritanont T
    Drug Metab Dispos; 2012 May; 40(5):952-62. PubMed ID: 22328584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-based formulations to enhance oral bioavailability of the poorly water-soluble drug anethol trithione: effects of lipid composition and formulation.
    Han SF; Yao TT; Zhang XX; Gan L; Zhu C; Yu HZ; Gan Y
    Int J Pharm; 2009 Sep; 379(1):18-24. PubMed ID: 19508887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lipid vehicle and P-glycoprotein inhibition on the mesenteric lymphatic transport of paclitaxel in unconscious, lymph duct-cannulated rats.
    Cai Q; Deng X; Li Z; An D; Shen T; Zhong M
    Drug Deliv; 2016; 23(1):147-53. PubMed ID: 24786483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analogues.
    Caliph SM; Faassen WA; Vogel GM; Porter CJ
    Curr Drug Deliv; 2009 Aug; 6(4):359-66. PubMed ID: 19534711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats.
    Sun M; Zhai X; Xue K; Hu L; Yang X; Li G; Si L
    Eur J Pharm Sci; 2011 Jun; 43(3):132-40. PubMed ID: 21530655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.